Xencor | Passivo Circulante

Current Liabilities Alterar Data
AbbVie USD 41.52B 6.75B 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Amgen USD 19.71B 1.32B 2024-03
Arrowhead Research USD 65.18M 1.45M 2024-03
AstraZeneca USD 28.9B 1.64B 2024-03
Biogen USD 3.22B 211.5M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Cytokinetics USD 88.85M 13.82M 2024-03
GlaxoSmithKline GBP 19.85B 1.22B 2024-03
J&J USD 48.72B 4.36B 2024-03
MacroGenics USD 55.76M 344K 2024-03
Merck USD 25.1B 2.01B 2024-03
Novartis USD 29.29B 2.9B 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 24.82B 1.38B 2023-12
Xencor USD 79.4M 5.31M 2024-03



Xencor Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.